期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Qingre Lishi Tuihuang therapy for acute icteric hepatitis B: A systematic review
1
作者 Zisong Wang Xueqian Wang +5 位作者 Jiajie Zhu Fafeng Cheng Haiqiang Yao Zheng Yang Zengliang Zhang Qingguo wang 《Journal of Traditional Chinese Medical Sciences》 2017年第2期95-105,共11页
Objective:To assess the efficacy of Qingre Lishi Tuihuang therapy (QLTT) for acute icteric hepatitis B infection.Methods:Eight electronic databases were searched from inception to December 2016 with no language restri... Objective:To assess the efficacy of Qingre Lishi Tuihuang therapy (QLTT) for acute icteric hepatitis B infection.Methods:Eight electronic databases were searched from inception to December 2016 with no language restrictions for reports of randomized controlled trials evaluating the effect of QLTT treating acute icteric hepatitis B.Two researchers independently extracted detailed data and assessed methodological quality.ReviewManager 5.3.0 software was used to analyze the data.Results:A total of 13 randomized controlled trials involving 2238 participants were included in this review.The methodological quality was generally poor.The results indicated that supplemented Yinchenhao decoction combined with non-specific treatments was more effective in improving the cure rate (risk ratio =1.80;95% CI 1.21-2.68) and reducing the serum levels of total bilirubin (mean difference =-29.74;95% CI-31.91 to-27.57) and aspartate aminotransferase.Other self-made prescriptions conforming to QLTT plus non-specific treatments had beneficial effect for acute icteric hepatitis B in curing this disease (risk ratio =1.48;95% CI 1.27-1.73),as well as for negative seroconversion of HBeAg (risk ratio =1.39;95% CI 1.11-1.74).Supplemented Yinchenhao decoction plus non-specific treatments was more effective than other self-made prescriptions conforming to QLTT in reducing serum total bilirubin level.Conclusion:Qingre Lishi Tuihuang therapy appears to improve effect based on non-specific treatments for the treatment of acute icteric hepatitis B.However,it is premature to draw confirmative conclusions,owing to the poor methodological quality and high clinical heterogeneity of the included trials.Further well-designed clinical randomized controlled trials with large sample sizes should be undertaken. 展开更多
关键词 Qingre Lishi Tuihuang THERAPY ACUTE icteric HEPATITIS B Systematic REVIEW TRADITIONAL Chinese MEDICINE
下载PDF
Diagnosis and treatment of icteric hepatitis caused by erythropoietic protoporphyria:A case report 被引量:1
2
作者 Hanqing Huang Leiqin Cai +1 位作者 Xinhua Li Shuru Chen 《Liver Research》 CSCD 2022年第2期116-120,共5页
Erythropoietic protoporphyria(EPP)is a rare inherited disease caused by partial deficiency activity of the enzyme ferrochelatase(FECH),resulting in excessive accumulation of protoporphyrin IX in erythrocyte and tissue... Erythropoietic protoporphyria(EPP)is a rare inherited disease caused by partial deficiency activity of the enzyme ferrochelatase(FECH),resulting in excessive accumulation of protoporphyrin IX in erythrocyte and tissues.Here,we report a patient with photosensitive dermatitis and acute icteric hepatitis caused by EPP,whose clinical and biochemical results successfully improved following 2-month treatment with glucose load,ursodeoxycholic acid capsules,and cholestyramine powder.This case provides a reference for a combination therapy strategy for patients with liver and skin injury caused by EPP. 展开更多
关键词 Erythropoietic protoporphyria(EPP) Inherited disease Photosensitive dermatitis JAUNDICE Ferrochelatase(FECH) Liver injury icteric hepatitis
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部